Discovering a New Cancer Killer

Dr. Marek Los (2004 Research Grant) 

Marek Los’ research story is classic. While studying the process of cell death he stumbled upon a protein called apoptin which kills cancer cells while sparing healthy cells. Apoptin is sneaky. Cancer cells use certain pathways to keep themselves alive. Apoptin hijacks these pathways and redirects them to kill cancer cells. Even better, apoptin seems to work especially well in hormone refractory prostate cancer – a stage of cancer that is nearly impossible to treat. More research is needed but Los’ work may lead to new treatment options.

Help us take the first steps toward prevention. Donate Now




Subscribe to our free monthly e-newsletter!

* indicates required

 





 
PCC Spotlight
Do men’s toenails contain clues about prostate cancer prevention?

Toronto, January 29, 2018 – Funded by Prostate Cancer Canada (PCC), Dr.
More

Discovery of a promising new medication to block 'master key' of cancer growth

Vancouver, BC – For years, researchers have investigated approaches to prevent cancer-causing cells from multiplying in the body.
More

RFP: Content Development and Delivery of an Accredited Electronic Continuing Medical Education Course for Prostate Cancer Specialists

Prostate Cancer Canada invites applications from service providers interested in the development, promotion and delivery of an accredited electronic Continuing Medical Education course targeting prostate cancer specialists, including urologists.
More


Click here for news archive